Brief: Embecta Q4 Revenue USD 286.1 Million Vs. IBES Estimate USD 277 Million
26/11/2024 11:30
Nov 26 (Reuters) - Embecta Q4 gross profit USD 173.8 million. * Q4 adjusted operating income USD 61.2 million vs. IBES estimate USD 52.5 million * Q4 operating income USD 26.2 million * Q4 adjusted gross profit USD 178.3 million * Q4 net income USD 14.6 million * Q4 dividend USD 0.15 * Q4 adjusted EBITDA USD 73 million
Recent news on Embecta
See all newsEmbecta Corp. reports results for the quarter ended June 30 - Earnings Summary
Brief: Embecta Reports Third Quarter Fiscal 2026 Financial Results
Brief: Embecta Outlook FY Adjusted EPS USD 0.27 Vs. IBES Estimate USD 1.59
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel